newsfilter
← Latest News
PR Newswire·

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes

Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day...